Penelitian ini bertujuan menganalisis pengaruh efisiensi pengelolaan limbah, green accounting, dan kinerja lingkungan terhadap kinerja keuangan perusahaan farmasi yang terdaftar di Bursa Efek Indonesia periode 2022–2024. Penelitian menggunakan pendekatan kuantitatif dengan sampling jenuh terhadap 36 data observasi perusahaan yang terdaftar di BEI dan mengikuti PROPER. Data dianalisis menggunakan regresi linear berganda. Efisiensi pengelolaan limbah diukur melalui rasio produksi terhadap limbah B3, green accounting melalui rasio biaya lingkungan terhadap beban operasional, kinerja lingkungan melalui skor PROPER, dan kinerja keuangan melalui ROA. Hasil penelitian menunjukkan bahwa ketiga variabel pengelolaan lingkungan berpengaruh positif dan signifikan terhadap kinerja keuangan. Temuan ini menunjukkan bahwa pengelolaan limbah yang efisien, penerapan green accounting, dan peningkatan kinerja lingkungan dapat mendukung profitabilitas sekaligus keberlanjutan perusahaan. Penelitian ini memberikan bukti empiris mengenai pentingnya integrasi pengelolaan lingkungan dalam strategi keuangan perusahaan farmasi. This study aims to analyze the effects of waste management efficiency, green accounting, and environmental performance on the financial performance of pharmaceutical companies listed on the Indonesia Stock Exchange during 2022–2024. A quantitative approach was employed using saturated sampling, resulting in 36 observations from companies listed on the IDX and participating in the PROPER program. Data were analyzed using multiple linear regression. Waste management efficiency was measured by the production-to-B3 waste ratio, green accounting by the ratio of environmental costs to operating expenses, environmental performance by PROPER scores, and financial performance by ROA. The results show that waste management efficiency, green accounting, and environmental performance each have a positive and significant effect on financial performance. These findings indicate that efficient waste management, green accounting practices, and improved environmental performance can enhance profitability while supporting corporate sustainability. The study provides empirical evidence on the importance of integrating environmental management into the financial strategies of pharmaceutical companies.
Copyrights © 2026